Table 2.
Results from univariate and multivariate analysis of the relationship between comorbidities and type of pain.
Neuropathic | Nociceptive | Univariate | Multivariate | |
---|---|---|---|---|
Age* | 55.2 ± 8.6 | 52.9 ± 11.4 | 0.2 | |
Duration of the disease* | 10.2 ± 7.8 | 9.8 ± 6.7 | 0.9 | |
Treatment with bDMARD (yes/no) (%) | 29.6 | 19.0 | 0.2 | |
mMASES* | 2.5 ± 2.7 | 0.8 ± 1.4 | 0.001 | |
BMI* | 28.2 ± 5.3 | 26.6 ± 4.9 | 0.09 | |
Leptin (ηg/mL)* | 26.8 ± 21.6 | 14.2 ± 13.5 | 0.001 | OR: 1.03(1.007–1.056); p < 0.01** |
HADS-D* | 7.6 ± 4.10 | 3.9 ± 3.4 | 0.001 | |
HADS-A* | 9.8 ± 3.7 | 5.8 ± 3.9 | 0.001 | |
ISI* | 14.5 ± 6.1 | 7.3 ± 4.9 | 0.001 | OR: 1.19(1.09–1.297); p < 0.001** |
HADS-D and HADS-A, Depression and Anxiety subscales of the Hospital Anxiety and Depression Scale respectively; ISI, Insomnia Severity Index. *Values in cells represent (mean ± SD). **Nagelkerke R2: 0:52.